SECTORAL ASSET MANAGEMENT INC - ASCENDIS PHARMA A/S ownership

Back to all holdings Add to watchlist

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

Links
Filings
External links
Quarter-by-quarter ownership
SECTORAL ASSET MANAGEMENT INC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$397,127
+59.1%
4,241
+51.7%
0.08%
+83.3%
Q2 2023$249,543
+37.7%
2,796
+65.4%
0.04%
+20.0%
Q1 2023$181,202
-12.2%
1,6900.0%0.04%
-12.5%
Q4 2022$206,400
+5.8%
1,690
-10.6%
0.04%
+5.3%
Q3 2022$195,000
+10.8%
1,8900.0%0.04%
+8.6%
Q2 2022$176,000
-75.5%
1,890
-69.2%
0.04%
-72.7%
Q1 2022$719,000
-12.8%
6,1290.0%0.13%
+3.2%
Q4 2021$825,000
-86.6%
6,129
-84.1%
0.12%
-75.8%
Q3 2021$6,160,000
+1219.1%
38,650
+988.7%
0.51%
+1247.4%
Q2 2021$467,000
+11.5%
3,550
+9.2%
0.04%
+18.8%
Q1 2021$419,000
-27.4%
3,250
-89.5%
0.03%
+14.3%
Q1 2016$577,000
+1.2%
31,1000.0%0.03%
+16.7%
Q4 2015$570,000
+3.6%
31,1000.0%0.02%
-4.0%
Q3 2015$550,000
-86.8%
31,100
-86.8%
0.02%
-85.6%
Q2 2015$4,165,000
-67.2%
235,560
-67.8%
0.17%
-63.9%
Q1 2015$12,694,000–731,660–0.48%–
 Download
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,797,745$265,886,00019.06%
RA Capital Management 4,914,955$726,922,00014.16%
Sofinnova Investments, Inc. 1,109,874$164,150,00010.35%
Eventide Asset Management 1,709,848$252,887,0005.50%
Asymmetry Capital Management, L.P. 47,599$7,040,0005.39%
BERYLSON CAPITAL PARTNERS, LLC 58,200$8,608,0005.30%
Avoro Capital Advisors LLC 1,750,000$258,825,0005.12%
Eversept Partners, LP 220,344$32,588,8784.47%
Spyglass Capital Management LLC 452,104$66,866,0004.14%
Orbimed Advisors 1,562,986$231,166,0003.25%
View complete list of ASCENDIS PHARMA A/S shareholders